Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Dyspnea Article
This is a selection made from among articles on Drug Treatment Dyspnea. For a permanent link to this article, or to bookmark it for future reading, click here.
When Do You Need Alcohol Addiction Treatment?
from:by David Richards
Most of us like to drink and have a good time. 'Partying' is just a harmless recreational use of drinking. But, when is it too much? How can you tell if you are addicted? And when should you consider alcohol addiction treatment? First, what does it mean to be addicted to something? This means that we crave it all the time. Strangely enough, the addicted person often does not recognize it. Yet, they can not go without. Dependence on drugs and booze is a big problem in the United States. It affects nearly everyone. And, dependence destroys lives. It often works subtly, so the afflicted person thinks the problem is with everyone else. Dependence doesn't just destroy the addicted person's life, but the lives of those who love him and must deal with the problems, too. It is everyone's problem. Dependence is different from abuse. It is possible for someone to abuse drugs without becoming addicted, but most often the two go hand in hand. When things get out of hand, it is time to get treated. Throughout our teenage years, we are bombarded with images in popular culture of drugs. Partying is seen as a normal course in a person's life. Indeed, most of us have some pretty wild times when we are young. We also see images of the darker side of drug abuse. There is never a shortage of 'Behind the Music' stories of celebrities who have gone over the edge and never come back. The collective shame we feel when we see a public figure destroy themselves that works as a deterrent. But, even the dark side of this story has a certain glamour and romance to it. When we are young, we start habits that can continue for a lifetime. It is not unusual for young people to experiment with drugs and party. But, for every group who come out unscathed, there are always casualties who develop destructive lifetime habits in their younger years. Studies have shown that the younger someone gets into drugs and drinking, the more likely they are to become addicted. This is why it's dangerous. Here are a few things that indicate an addiction or problem with drinking:-You try to hide it, and deny to everyone that you might have a drinking problem.-You feel guilty about how much you drink, and you make schemes to moderate it, but you just can't follow through.-Friends and relatives are concerned with your drinking, and it irritates you whenever anyone says anything. -You drink in the morning to relieve the hangover from last night ('hair of the dog')Often people who have a problem with one drug can easily develop a problem with another. This is something you have to watch your whole life. If you become addicted to drink, you can easily become addicted to something else. It has been found that many people who become drug addicts start with legal drugs, like prescription drugs or inhalants. Dependence is a sneaky thing, and it usually comes from socially-accepted drug behavior first. This is how a guy who likes to party with his friends may end up an alcoholic a couple of years down the road. It is difficult to quit drinking. It may take more control than you can muster, and this is why we seek help from outside. If you have the support of your friends and loved ones, you can start to recover, but you have to want to do it. There is nothing wrong with seeking professional help. Many people overcome their problems through rehab. It helps to have a clutch to hang onto. For those who have severe drinking problems, it may actually be unhealthy to quit cold turkey. This is why being treated by trained professionals may be the best way.
David Richards is a publisher of alcoholism facts and related articles. You can go to 1st alcoholism treatment for more.
Drug Treatment Dyspnea Specific links
Drug Treatment Dyspnea News
Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line ...
Pfizer announced today that the Committee for Human Medicinal Products of the European Medicines Agency has adopted a positive opinion regarding the marketing authoriz
Read more...Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with ...
Sucampo Pharmaceuticals, Inc. today announced the presentation of pooled data from post-hoc analyses of the two pivotal Phase 3 studies of AMITIZA® for the treatment of irritable bowel syndrome with constipation at Digestive Disease Week 2012 in San Diego.
Read more...Press Release
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Read more...Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A
Baxter International Inc. today announced the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A in China by the State Food and Drug Administration .
Read more...Pfizers Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line ...
Pfizer announced today that the Committee for Human Medicinal Products ...
Read more...Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in ...
SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated announced today the opening to enrollment of the second cohort in the ongoing, international, randomized, double-blind, placebo-controlled Phase IIb ...
Read more...Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. today announced the presentation of positive data from a Phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction , at Digestive Disease Week 2012, held in San Diego, California.
Read more...Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell ...
Pfizer Inc announced today that the Phase 3 INTORSECT study, evaluating TORISEL® in patients with advanced renal cell carcinoma whose disease had progressed on or after SUTENT® therapy, did not meet the primary endpoint of prolonging progression free survival when compared to sorafenib.
Read more...MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma Exacerbations
Company Intends to Move Forward With End-of-Phase 2 Meeting With FDA and Phase 3 Clinical Development
Read more...New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly ...
Celgene International Sàrl, a subsidiary of Celgene Corporation , today announced that results from three phase III studies evaluating the use of continuous REVLIMID® treatment in newly diagnosed multiple myeloma patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.
Read more...